- Home
- AMBC vs PCRX Comparison
AMBC vs PCRX Comparison
Compare AMBC & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- PCRX
- Stock Information
- Founded
- AMBC 1971
- PCRX 2006
- Country
- AMBC United States
- PCRX United States
- Employees
- AMBC N/A
- PCRX N/A
- Industry
- AMBC Property-Casualty Insurers
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- AMBC Finance
- PCRX Health Care
- Exchange
- AMBC Nasdaq
- PCRX Nasdaq
- Market Cap
- AMBC 411.3M
- PCRX 1.2B
- IPO Year
- AMBC 1991
- PCRX 2011
- Fundamental
- Price
- AMBC $7.01
- PCRX $22.90
- Analyst Decision
- AMBC Strong Buy
- PCRX Buy
- Analyst Count
- AMBC 1
- PCRX 8
- Target Price
- AMBC $15.00
- PCRX $28.38
- AVG Volume (30 Days)
- AMBC 938.8K
- PCRX 545.0K
- Earning Date
- AMBC 08-04-2025
- PCRX 07-29-2025
- Dividend Yield
- AMBC N/A
- PCRX N/A
- EPS Growth
- AMBC N/A
- PCRX N/A
- EPS
- AMBC N/A
- PCRX N/A
- Revenue
- AMBC $253,912,000.00
- PCRX $702,772,000.00
- Revenue This Year
- AMBC N/A
- PCRX $7.54
- Revenue Next Year
- AMBC $17.41
- PCRX $10.78
- P/E Ratio
- AMBC N/A
- PCRX N/A
- Revenue Growth
- AMBC 125.08
- PCRX 3.08
- 52 Week Low
- AMBC $5.99
- PCRX $11.16
- 52 Week High
- AMBC $13.64
- PCRX $27.64
- Technical
- Relative Strength Index (RSI)
- AMBC 44.35
- PCRX 35.82
- Support Level
- AMBC $6.97
- PCRX $22.82
- Resistance Level
- AMBC $8.07
- PCRX $23.83
- Average True Range (ATR)
- AMBC 0.31
- PCRX 0.74
- MACD
- AMBC 0.05
- PCRX -0.02
- Stochastic Oscillator
- AMBC 25.35
- PCRX 6.22
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.